Established, Scalable & Rapidly-Growing

CritiTech Particle Engineering Solutions (CT PES) is an established, growing, pharmaceutical Contract Development Manufacturing Organization (CDMO) with extensive experience and expertise in particle engineering, material characterization, analytical testing, early stage drug development, pre-clinical and clinical manufacturing.  The company utilizes Spray Drying and Supercritical Precipitation to help its customers develop their drugs.  CT PES provides its drug development and manufacturing services from proof-of-concept through Phase II cGMP production.  It has produced cGMP materials related to four drugs that are currently being tested in a total of six clinical trials.  Clients range from three “Top 15” pharmaceutical companies to pharmaceutical and biotechnology start-ups.  CT PES is located in Lawrence, Kansas, home of the University of Kansas School of Pharmacy.

CritiTech Team

CritiTech Particle Engineering Solutions has assembled a team with deep pharmaceutical experience whose number one priority is serving the drug development needs of our clients.  Our talented and driven staff has decades of experience in particle engineering, early stage drug development, formulation, material characterization, analytical testing, pre-clinical and clinical manufacturing, quality operations and corporate management serving positions at Sandoz, Sanofi-Aventis, Merck, Cardinal Health, Celliance, Quintiles, CareFusion and Plastikon.

Sam Campbell
Chairman
Matt McClorey
President
Michael Baltezor, PhD
Chief Scientific Officer
Jeffrey Morrison
Chief Financial Officer
Larry Dickinson
Chief Commercial Officer
Mark Williams
VP of Technical Operations
Jahna Espinosa
Director of Laboratory Operations
Richard Ramos
Director of Support Services
Joseph Farthing
Manager of Analytical Services and Product Characterization
Jake Sittenauer
Manager Drug Development Services
Leah Claypool
Laboratory Technician
Bala Subramaniam, PhD
Founder
Shelby Clark
Intern
Jamie Blaylock
Quality Documentation Specialist
John Reynolds
Director Quality Operations